Clinical trial
Airway Clearance Study
NCT00379028 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00379028 |
|---|---|
| Title | Airway Clearance Study |
| Official title | A Randomized, Double-blind, Two-way Cross-over Study Evaluating Systemic Bioavailability and Airway Clearance of SymbicortTurbuhaler 320/9mcg vs SeretideDiskus 50/500mcg After Single Inhalations in Patients With COPD and Healthy Volunteers |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | Budesonide/Formoterol Turbuhaler, Salmeterol/Fluticasone Diskus |
| Enrollment | 54 |
| Start date | Sep 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Sep 21, 2006 |
| Last update posted | Jan 24, 2011 |
| Countries | Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: